Ruxolitinib (Jakafi) does not prevent complications due to COVID-19 associated cytokine storm: Study
There was no reduction in the proportion of patients receiving ruxolitinib plus SoC who experienced severe complications including…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.